Introduction
The use of chest tubes is aimed to preserve hemodynamic stability and cardiopulmonary function by draining fluids, blood and air from the pleural, pericardial or mediastinal cavities (1) . Removing chest tubes is painful, largely because the visceral pericardium and pleura are rich in nociceptive fibers (2) . The removal of chest tubes represents a potential stimulus for the intercostal nerve fibers that innervate the parietal pleura, chest muscles, and insertions of chest tubes (3) .
The adverse effects of this painful procedure have not yet been duly investigated, and little is known about the measures applied in intensive care units (ICU) to control pain related to painful procedures. This lack of knowledge may contribute to an increase in postoperative pulmonary complications, such as a decrease in respiratory muscle strength, pulmonary volumes and capacity, as well as reducing the effectiveness of cough and causing an increase in the number of pulmonary infections. These complications interfere with the clinical progression of patients and are considered the main causes of morbidity and mortality in such cases (1) .
The scope of analgesic protocols is quite wide, ranging from non-pharmacological techniques, relaxation exercise with opioids, opioids alone (4) and ice packs (5) , through to the use of drugs such as morphine and local anesthetics.
Some approaches combine various drugs to improve analgesia while reducing their side effects. Systemic multimodal, or balanced, analgesia consists of intravenous administration of non-steroidal anti-inflammatory drugs combined with weak and strong opioids (3) .
Various studies have examined medical treatments designed to relieve chest tube removel (CTR) pain, including remifentanyl (6) , sulfentanyl (7) fentanyl (8) , intravenous paracetamol (9) , cold application in combination with indomethacin suppository (10) , morphine, subcutaneous bupivacaine and Entonox (nitrous oxide 50% and oxygen 50%), with no statistical difference (11) , and morphine and ketorolac, again with no statistical difference (12) .
One of the main analgesic techniques consists of the subcutaneous administration of lidocaine, which is used to control pain in several procedures, such as venous and arterial puncture, venous and arterial catheter insertion, and chest tube removal, among others. Nevertheless, patients are often not given analgesics or any other procedure to control pain (13) .
As pain is an expected occurrence when drains are removed, analgesics should be administered to patients appropriately before chest tube removal to achieve satisfactory effects. The objective of the present study was to analyze the analgesic effect of 1% subcutaneous lidocaine combined with multimodal analgesia or an intravenous (IV) analgesic regime by means of systematic assessment of the intensity of pain during chest tube removal following heart surgery.
Methods
The present study was a randomized controlled clinical trial that was approved by the Research Ethics (14) . This scale scores sedation at six different levels, as follows: 1-anxiety and/or agitation;
2-tranquility, cooperation and orientation; 3-response to commands only; 4-brisk response to auditory or painful stimulus; 5-sluggish response to auditory or painful stimulus; and 6-no response. Only individuals at levels ≤ 3
were included. Individuals who declared a wish to withdraw from the study were excluded, as were individuals who developed postoperative complications, including severe heart and/or respiratory failure and stroke, or who required reoperation from any cause. Figure 1 depicts the flowchart of the study participants.
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At the preoperative visit, after the informed consent form was signed, all of the participants were trained in the use of a 10-cm visual analog scale (15) (VAS) for pain and were advised to describe the quality of pain using the short-form McGill Pain Questionnaire (descriptors) (16) . On that occasion, the participants were also instructed on how to behave upon waking up after surgery at the ICU, as, in order to better assess their pain, it is better for them to be thoroughly acquainted with both instruments. Finally, the participants' levels of anxiety were assessed using STAI (State-Trait Anxiety Inventory) and Spielberger's theoretical framework (17) .
The doctors and nurses at the institution where the study was conducted established that the chest tubes would be removed 24 hours after surgery. The number, size, and position of the chest tubes were selected according to surgical need. Tube sizes 19F and 28F are routinely used for chest drainage at the institution where the study was followed.
The individual needs of additional analgesia were recorded for all experimental and control patients following the standardization of the ICU post-operative analgesia.
Before the removal of the chest tubes, the participants were randomly allocated to the study groups by the cardiologists using a computer-based database that had been previously established. In addition to the standard analgesic regime used at the ICU where the study was conducted for patients after heart surgery, the participants in the experimental group were given four subcutaneous injections of 1% lidocaine at approximately one cm from the surgical wound margin using 7 mm in a diamond pattern; the volume of each dose was 2.0 ml, for a total of 8.0 ml. The participants in GII were only given one multimodal analgesic (3) , which consisted of the administration of non-steroidal antiinflammatory drugs combined with weak and strong opioids by IV based on the systematic assessment of the pain intensity (visual analog scale -VAS) (15) : pain < 3 (weak analgesic), dipyrone IV 30 mg/kg every six hours; pain = 4 to 7, tramadol IV 50 mg/kg every six hours; and pain = 8 to 10, morphine IV 1 to 2 mg. The chest tubes were removed by the surgeon. Following the procedure, nurses were blinded to the composition of the study groups and assessed the participants when the surgeon was not present.
In the statistical analysis, for the descriptive analysis, the categorical data were arranged in tables of absolute and relative frequencies. As the distribution of the quantitative data was not normal, the data were 
Results
The initial sample was comprised of 60 participants.
However, two individuals in the control group did not complete the study, with one case requiring reinsertion of the chest tubes and another refusing to participate in the assessments. Therefore, 58 participants were assessed after surgery. Thirty-six (62.1%) participants were male, and 22 (37.9%) were female; the average age of the sample was 59.78 (± 8.93) years old.
The groups did not exhibit significant difference with respect to gender, age, surgery time, hospital stay and ASA physical status. Table 1 describes the distribution of the results with respect to the assessment of anxiety.
Most of the participants exhibited low-to-average and mild-to-moderate levels of trait and state anxiety, respectively. Significant association was not observed between the levels of anxiety and the study groups.
With respect to the assessment of pain as a function of lidocaine injection, there was no association between the presence of pain and groups (p= 0.42), as Table 2 shows. In addition, the median intensity of pain with respect to lidocaine injection did not differ between the groups (p= 0.27).
With respect to chest tube removal, no association was observed between group and anxiety level (p= 0.94) or pain before the procedure (p= 0.67), as shown in Table 3 . The median intensity of pain upon removal of pleural or mediastinal chest tubes did not differ significantly between the groups. 
Discussion
There is evidence that adequate pain control is significantly beneficial for patient comfort. Although multimodal analgesia combined with lidocaine is considered an option for chest tube removal, this therapy was not effective in the present study.
Although no association was observed between trait and state anxiety and group, and despite the orientations and psychological support provided by the nurses as a part of the routine care before the procedure, almost half of the participants exhibited moderate anxiety.
Almost one-third of the participants reported the presence of pain before chest tube removal. Both groups localized the majority of their pain to the sternotomy site, as well as the site of chest tube insertion, particularly in the case of the pleural drains, followed by the saphenectomy site. These findings agree with previous studies, where pain occurred at the sternotomy site up to postoperative day three (18) (19) .
There was no significant difference in pain associated with the subcutaneous administration of lidocaine between the groups. In this regard, it is worth noting that the intensity of pain reported was mild, which might be related to the use of multimodal analgesia. According to the literature (20) , discomfort and pain during the subcutaneous administration of lidocaine is reported by patients as a whole. These symptoms might be related to the needle gauge, anesthetic administration speed, injected solution volume or temperature, patient profile, or the low pH of the anesthetic.
The groups did not exhibit significant differences in pain associated with the procedure for CTR. However, the participants in the experimental group (GI) qualified the pain upon removal of mediastinal chest tubes as intense, followed by moderate in almost one-third of the cases. Most studies found that patients felt moderate-tosevere pain during chest tube removal despite the administration of morphine or local anesthetics (21) .
One study compared the efficacy of remifentanyl 0.5 mg/kg versus placebo for alleviating pain due to chest tube removal. The results revealed that the patients receiving remifentanyl exhibited significantly less pain than did those receiving a placebo at drain removal (6) . In another study (7) significantly lower pain scores were reported in the groups treated with fentanyl 2 µg/kg IV or sufentanyl 0.2 µg/kg IV, compared with the patients in the control group who were given 2 ml of normal saline.
Chest tube removal and pleural drains in particular are considered a determinant factor for the development of intense pain after cardiac surgery. It is also observed that removal of pleural chest tubes is more painful compared with mediastinal drains (2) .
Furthermore, some patients report that the pain or the discomfort caused by the procedure is one of the worst experiences in ICU. Insertion of pleural drains is unavoidable during pleurotomy and causes traumatic chest injuries due to the perforation of the intercostal muscles and parietal pleura, which interferes with the respiratory movements and the position of the pleural drains (22) (23) . Another study (24) demonstrated that patients with subxiphoid pleural drains reported less pain compared with the ones with intercostal insertion.
Similar findings were reported (25) and described a technique of subxiphoid pleural drain insertion to reduce postoperative discomfort due to the chest tube friction against the intercostal space.
participants to describe pain were pressing, sharp, pricking, and burning, and the most common site of pain was the drain site (65.0%). Using the same instrument and type of population, one study (2) reported that the words used to describe the pain caused by chest tube removal were fearful (44.8%), sharp and tender (40.3%), and hot-burning using the same instrument in the same population.
Regarding the effectiveness of other nonpharmacological therapies for pain control in the CTR, cold application, which seemed to be a noninvasive and safe way to reduce pain, in a systematic review that analyzed data from 426 patients, 05 trials showed conflicting results (5) . However, the study of Demir and Khorshid (26) found that cold application reduced patients' intensity of pain due to CTR but did not affect anxiety levels or the type of pain. They nevertheless recommended cold as a pain-relieving technique during CTR.
As a possible limitation of the present study, we believe that the fact that the number of participants may have some kind of influence on the results. Therefore, the findings cannot be generalized to other patients who experience CTR. It is recommended that the study be repeated with more patients who experience CTR for other reasons. The present study was designed in two groups; as a result, the possible placebo effect on the patients' pain perception was not identified. It is recommended that a similar study in three groups be conducted to exclude the placebo effect. In our study, patients might have responded differently to pain based on their physical condition, emotional and cultural states.
Further studies in different settings are suggested.
Conclusion
Thus, the present study suggests that the analgesic effect of the subcutaneous administration of 1% lidocaine combined with multimodal analgesia is less effective and subcutaneous injections are less effective in relieving pain.
